FLUX vs CBAT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

FLUX

32.9
AI Score
VS
FLUX Wins

CBAT

32.6
AI Score

Investment Advisor Scores

FLUX

33score
Recommendation
EXTENDED

CBAT

33score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric FLUX CBAT Winner
Forward P/E 28.8184 6.105 CBAT
PEG Ratio 0 0 Tie
Revenue Growth -50.7% 99.3% CBAT
Earnings Growth 0.0% 15062.1% CBAT
Tradestie Score 32.9/100 32.6/100 FLUX
Profit Margin -17.7% -7.4% CBAT
Beta 1.00 1.00 Tie
AI Recommendation EXTENDED AVOID NEW MONEY FLUX

Relative Price Performance (Last 90 Days)

FLUX 1M: +18.5% · 3M: -21.9% CBAT 1M: +39.0% · 3M: +153.7%

Current Technical Phase

FLUX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 61

RSI (14): 60.6 · Price: $0.64

CBAT

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (37.6% over 20 days), RSI 67

RSI (14): 67.0 · Price: $1.39

Fundamentals Snapshot

Metric FLUX CBAT
Market Cap — —
Forward P/E -2.5 5.8
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.5% 1.0%
Gross Margin 0.3% 0.1%
Operating Margin -0.3% -0.1%
EPS -0.35 -0.18
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, FLUX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.